Cross-cultural adaptation and validation of the `Multiple Sclerosis Quality of Life Instrument' in Hungarian

Abstract

Health-related quality of life measurements are gaining more importance in the study and clinical practice of multiple sclerosis. The aim of our study was the adaptation of the Multiple Sclerosis Quality of Life Instrument (MSQOL-54) in Hungarian. The study was carried out at the Department of Neurology, University of Szeged and two other multiple sclerosis centers. The Hungarian translation of the questionnaire was given to patients at the outpatient units of the neurology departments. The EDSS score of the patients were determined and data concerning the onset and the clinical form of the disease was collected. Altogether 438 patients filled out the questionnaire. We enrolled patients with all clinical forms of the disease. Cronbach's alpha coefficients were over 0.8 in case of all scales except `Rolelimitations — emotional' (0.794), indicating a good internal consistency reliability for group comparisons. The instrument was able to distinguish between known clinical group differences. The Hungarian version of the MSQOL-54 instrument shows good psychometric properties similar to the original questionnaire. Multiple Sclerosis 2008; 14: 391—398. http://msj.sagepub.com

Keywords

Get full access to this article

View all access options for this article.

References

Vickrey BG , Hays RD , Harooni R. , Myers LW , Ellison GW A health-related quality of life measure for multiple sclerosis. Qual Life Res 1995; 4: 187-206.

Ware JE Jr. , Sherbourne CD. The MOS 36-item short-form health survey (SF-36) I. Conceptual framework and item selection. Med Care 1992; 30: 473-83.

McHorney CA , Ware JE , Raczek AE The MOS 36-item short-form health survey (SF-36): II. Psychometric and clinical tests of validity in measuring physical and mental health constructs . Med Care 1993; 31: 247-63.

Solari A. , Filippini G. , Mendozzi L. , Ghezzi A. , Cifani S. , Barbieri E. et al. Validation of Italian multiple sclerosis quality of life 54 questionnaire. J Neurol Neurosurg Psychiatry 1999; 67: 158-62.

Vernay D. , Gerbaud L. , Biolay S. , Coste J. , Debourse J. , Aufauvre D. et al. Quality of life and multiple sclerosis: validation of the French version of the self-questionnaire (SEP-59). Rev Neurol 2000; 156: 247-63.

Acquadro C. , Lafortune L. , Mear I. Quality of life in multiple sclerosis: translation in French Canadian of the MSQoL-54. Health Qual Life Outcomes 2003; 1: 70.

Idiman E. , Uzunel F. , Ozakbas S. , Yozbatiran N. , Oguz M. , Callioglu B. et al. Cross-cultural adaptation and validation of multiple sclerosis quality of life questionnaire (MSQOL-54) in a Turkish multiple sclerosis sample . J Neurol Sci 2006; 240: 77-80.

Aymerich M. , Guillamón I. , Perkal H. , Nos C. , Porcel J. , Rajmil L. et al. Validation of the Spanish version of the MSQOL-54. Mult Scler 2005; 11: (Suppl 1) 361.

Yamamoto T. , Ogata K. , Katagishi M. , Shimizu H. , Ogawa M. , Yamamura T. et al. Validation of the Japanese-translated version Multiple Sclerosis Quality of Life-54 instrument. Rinsho Shinkeigaku 2004; 44: 417-21. (article in Japanese).

10.

Scientific Advisory Committee of the Medical Outcomes Trust. Assessing health status and quality-of-life instruments: attributes and review criteria. Qual Life Res 2002; 11: 193-205.

11.

Bullinger M. , Alonso J. , Apolone G. , Leplège A. , Sullivan M. , Wood-Dauphinee S. et al. for the IQOLA Project Group. Translating health status questionnaires and evaluating their quality: the IQOLA project approach . J Clin Epidemiol 1998; 51: 913-23.

12.

Ware JE, Jr. , Gandek B for the IQOLA Project Group. Methods for testing data quality, scaling assumptions, and reliability: the IQOLA project approach . J Clin Epidemiol 1998; 51: 945-52.

13.

Gandek B. , Ware JE, Jr. , for the IQOLA Project Group. Methods for validating and norming translations of health status questionnaires : the IQOLA project approach. J Clin Epidemiol 1998; 51: 953-59.

14.

Poser CM , Paty DW , Scheinberg L. , McDonald WI , Davis FA , Ebers GC et al. New diagnostic criteria for multiple sclerosis. Guidelines for research protocols. Ann Neurol 1983; 13: 227-31.

15.

Kurtzke JF Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 1983; 43: 655-61.

16.

Ware JE, Jr. , Kosinski M. , Gandek B. SF-36 Health survey: manual and interpretation guide. Lincoln, RI: Quality Metric Incorporated, 1993.

17.

Ware JE , Kosinski M. , Dewey JE How to score Version 2 of the SF-36 health survey. Lincoln , RI: Quality Metric Incorporated, 2000.

18.

Mattson D. , Petrie M. , Strivastava DK , McDermott M. Multiple sclerosis. Sexual dysfunction and its response to medications . Arch Neurol 1995; 52: 862-68.

19.

Zivadinov R. , Zordon M. , Locatelli L. , Stival B. , Monti F. , Nasuelli D. et al. Sexual dysfunction in multiple sclerosis: a MRI, neurophysiological and urodynamic study. J Neurol Sci 2003; 210: 73-76.

20.

Solari A. , Ferrari G. , Radice D. A longitudinal survey of self-assessed health trends in a community cohort of people with multiple sclerosis and their significant others. L Neurol Sci 2006; 243: 13-20.

21.

Gold SM , Schulz H. , Monch A. , Schulz KH , Heesen C. Cognitive impairment in multiple sclerosis does not affect reliability and validity of self-report health measures. Mult Scler 2003; 9: 404-10.

22.

McHorney CA , Tarlov AR Individual-patient monitoring in clinical practice: are available health status surveys adequate? Qual Life Res 1995; 4: 293-307.